Presidente Prudente, Brazil
Presidente Prudente, Brazil

Time filter

Source Type

Alfaro A.,Hospital Constitucion | Castrejon L.,Hospital Regional | Rodriguez Ortiz M.,Hospital Constitucion
Dermatologia Revista Mexicana | Year: 2010

Objective: To know the epidemiologic behavior of the different cutaneous malignant tumors observed in Nuevo Leon during 1999-2008. Patients and methods: We carried out a retrospective epidemiologic study of ISSSTE patients with positive biopsy for cutaneous malignant neoplasia, diagnosed between January 1999 and December 2008. The information was collected from the pathological reports obtained during this period and was verified with each patients' clinical file. This information was organized in an electronic data base and then analyzed. Results: Between 1999 and 2008, 591 patients were diagnosed with skin cancer; of them, 65% corresponded to basal cell carcinoma, 23% to squamous cell carcinoma, 6.5% to melanoma and 5.5% to other skin neoplasia. Conclusions: The study findings match central regions statistics of the country; however, it differs from the United States data which reports 75-85% of basal cell carcinoma.


PubMed | Hospital Universitario runa, Hospital Universitario La Paz, Hosital Universitari Vall dHebron, Hospital Universitari Joan and 14 more.
Type: | Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Year: 2016

Boceprevir (BOC) was one of the first oral inhibitors of hepatitis C virus (HCV) NS3 protease to be developed. This study assessed the safety and efficacy of BOC+pegylated interferon-2a/ribavirin (PEG-IFN/RBV) in the retreatment of HIV-HCV co-infected patients with HCV genotype 1.This was a phase III prospective trial. HIV-HCV (genotype 1) co-infected patients from 16 hospitals in Spain were included. These patients received 4 weeks of PEG-IFN/RBV (lead-in), followed by response-guided therapy with PEG-IFN/RBV plus BOC (a fixed 44 weeks was indicated in the case of cirrhosis). The primary endpoint was the sustained virological response (SVR) rate at 24 weeks post-treatment. Efficacy and safety were evaluated in all patients who received at least one dose of the study drug.From June 2013 to April 2014, 102 patients were enrolled, 98 of whom received at least one treatment dose. Seventy-three percent were male, 34% were cirrhotic, 23% had IL28b CC, 65% had genotype 1a, and 41% were previous null responders. The overall SVR rate was 67%. Previous null-responders and cirrhotic patients had lower SVR rates (57% and 51%, respectively). Seventy-six patients (78%) completed the therapy scheme; the most common reasons for discontinuation were lack of response at week 12 (12 patients) and adverse events (six patients).Response-guided therapy with BOC in combination with PEG-IFN/RBV led to an overall SVR rate of 67%, but an SVR rate of only 51% in patients with cirrhosis. The therapy was generally well tolerated. Although the current standards of care do not include BOC+PEG-IFN/RBV, the authors believe that this combination can be beneficial in situations where new HCV direct antiviral agent interferon-free therapies are not available yet.


News Article | March 2, 2017
Site: marketersmedia.com

Effort Poised to Result in Major Reductions in Surgical Costs and Improved Outcomes NEWPORT BEACH, CA / ACCESSWIRE / March 2, 2017 / ORHub, Inc. (OTC PINK: ORHB), a cloud-based health care software-as-a-service (SaaS) company focused on decreasing costs and increasing outcomes in surgical care, announces a new solution built on Microsoft Azure that's focused on the single biggest cost center for healthcare - surgery. Many hospitals and vendors today are struggling with rising costs, decreasing margins, and uneven quality, despite the hard work of well-intentioned, well-trained professionals. Without understanding the true costs of care for patient conditions, much less how costs are related to outcomes, health care organizations are flying blind in deciding how to improve efficiency and increase quality. Legacy delivery approaches, payment structures, and software which have largely remained unchanged for decades, have reinforced the problem and produced a system with erratic quality and unsustainable costs. ORHub has solved this problem by creating a value-based solution that tracks the cost of treating a condition from diagnosis to discharge, and then tracking outcomes that resulted from that treatment. ORHub's platform enables all parties involved in surgical care to organize, deliver, measure, and reimburse in a streamlined process. This allows for significant decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions that result from siloed processes in software and poor handoffs from one part of the care process to another. Installations of ORHub's solution are in full production usage daily at two major southern California hospitals, both of which are members of the nation's second largest non-profit hospital system. Hospital Regional President and CEO, Richard Afable, stated that ORHub was "one of those innovative new systems that can, and will, provide for us the kind of information, the kind of data that we need in order to take better care of patients and to do it more effectively and more efficiently." "We've had an extraordinarily productive year working with Microsoft," says Wesley Mitchell, Chief Technology Officer of ORHub. "We went from concept to production in less than a year in Institutional Medicine. We couldn't have done that without the knowledge and expertise of our friends at Microsoft. They cleared the way for us in terms of technology and regulatory safety by building platforms like Microsoft Azure which enables HIPAA compliance so that we could focus on what's most important to us: delivering value to our customers." ORHub worked with Microsoft for Startups on a variety of technical engagements that helped create the digital platform's initial architecture. The design of the solution is based on the recognition that today's siloed health care software is fundamentally incompatible with a value-based approach, which emphasizes that organizations wanting to practice value-based health care need software built from the ground-up with that goal in mind. "ORHub's solution on Microsoft Azure has the potential to have a big impact on one of the costliest areas of healthcare - surgery - bringing efficiencies to its customers and savings to patients," said Jim Brisimitzis, General Manager, Microsoft for Startups at Microsoft Corp. "Azure's global scale, security and compliance portfolio make it the ideal cloud platform for health organizations and the partners that serve them." During early product development, the Microsoft for Startups team also helped ORHub with customer introductions, which proved to be impactful for clearly understanding customer needs and helped the Company avoid potential pitfalls in structuring its technology and contracts. With a year of production in play, ORHub has received overwhelming interest in its platform, and is now in discussions with health care providers across the United States. Institutions that have adopted a value-based model have reaped savings of 20-40% on their overall cost of care. ORHub allows participating hospitals to avoid the long, drawn out consulting approach to adopting a value-based model by providing a comprehensive tool that is value-based by design. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities. ORHub recently launched its second major hospital customer, and plans to roll-out to 1,100 hospitals in the next 18 months. "Before we even wrote out our first architecture diagram, we were having coffee with Jim and planning out our strategy together. Jim didn't just give us software credits, he offered advice, introduced us to influencers, industry insiders, and sales veterans who he promptly converted to believers themselves. The army of people at Microsoft who help us every day with everything from technology to marketing advice are here because Jim recruited them," says Mitchell. "No one knows health care better than Microsoft and we are proud to announce initial positive results from our collaboration with the company." ORHub is a cloud-based software platform focused on delivering value-based medicine in surgical care. The company enables all parties involved in surgical care to work together to organize, deliver, measure and reimburse in a single uniform process. This allows for significant decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions that result from siloed processes in software and poor handoffs from one part of the care process to another. The need for ORHub is clear. Health care comprises more than 17% of US GDP at over $3 trillion dollars per year. With costs rising every year due to an aging population and more expensive treatments, providers are under severe pressure to become more efficient and reduce costs from payers who are aggressively reducing reimbursements and finally moving away from fee-for-service and toward performance-based reimbursement. ORHub enables providers to thrive in this new environment by addressing the single largest segment of health care, which is surgical care. ORHub replaces numerous legacy systems with a 360 degree system that is focused on tracking cost from diagnosis to discharge centered on treating a patient for a specific condition. ORHub has offices at Phoenix, Arizona; Newport Beach, California; and Bellevue, Washington. This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the Company believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurances that its expectations will be attained. Such statements are inherently uncertain, and actual results and activities may differ materially from those estimated or projected. Certain factors that can affect the Company's ability to achieve its anticipated results include, among others, uncertainties inherent in the development of a new software product business. Effort Poised to Result in Major Reductions in Surgical Costs and Improved Outcomes NEWPORT BEACH, CA / ACCESSWIRE / March 2, 2017 / ORHub, Inc. (OTC PINK: ORHB), a cloud-based health care software-as-a-service (SaaS) company focused on decreasing costs and increasing outcomes in surgical care, announces a new solution built on Microsoft Azure that's focused on the single biggest cost center for healthcare - surgery. Many hospitals and vendors today are struggling with rising costs, decreasing margins, and uneven quality, despite the hard work of well-intentioned, well-trained professionals. Without understanding the true costs of care for patient conditions, much less how costs are related to outcomes, health care organizations are flying blind in deciding how to improve efficiency and increase quality. Legacy delivery approaches, payment structures, and software which have largely remained unchanged for decades, have reinforced the problem and produced a system with erratic quality and unsustainable costs. ORHub has solved this problem by creating a value-based solution that tracks the cost of treating a condition from diagnosis to discharge, and then tracking outcomes that resulted from that treatment. ORHub's platform enables all parties involved in surgical care to organize, deliver, measure, and reimburse in a streamlined process. This allows for significant decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions that result from siloed processes in software and poor handoffs from one part of the care process to another. Installations of ORHub's solution are in full production usage daily at two major southern California hospitals, both of which are members of the nation's second largest non-profit hospital system. Hospital Regional President and CEO, Richard Afable, stated that ORHub was "one of those innovative new systems that can, and will, provide for us the kind of information, the kind of data that we need in order to take better care of patients and to do it more effectively and more efficiently." "We've had an extraordinarily productive year working with Microsoft," says Wesley Mitchell, Chief Technology Officer of ORHub. "We went from concept to production in less than a year in Institutional Medicine. We couldn't have done that without the knowledge and expertise of our friends at Microsoft. They cleared the way for us in terms of technology and regulatory safety by building platforms like Microsoft Azure which enables HIPAA compliance so that we could focus on what's most important to us: delivering value to our customers." ORHub worked with Microsoft for Startups on a variety of technical engagements that helped create the digital platform's initial architecture. The design of the solution is based on the recognition that today's siloed health care software is fundamentally incompatible with a value-based approach, which emphasizes that organizations wanting to practice value-based health care need software built from the ground-up with that goal in mind. "ORHub's solution on Microsoft Azure has the potential to have a big impact on one of the costliest areas of healthcare - surgery - bringing efficiencies to its customers and savings to patients," said Jim Brisimitzis, General Manager, Microsoft for Startups at Microsoft Corp. "Azure's global scale, security and compliance portfolio make it the ideal cloud platform for health organizations and the partners that serve them." During early product development, the Microsoft for Startups team also helped ORHub with customer introductions, which proved to be impactful for clearly understanding customer needs and helped the Company avoid potential pitfalls in structuring its technology and contracts. With a year of production in play, ORHub has received overwhelming interest in its platform, and is now in discussions with health care providers across the United States. Institutions that have adopted a value-based model have reaped savings of 20-40% on their overall cost of care. ORHub allows participating hospitals to avoid the long, drawn out consulting approach to adopting a value-based model by providing a comprehensive tool that is value-based by design. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities. ORHub recently launched its second major hospital customer, and plans to roll-out to 1,100 hospitals in the next 18 months. "Before we even wrote out our first architecture diagram, we were having coffee with Jim and planning out our strategy together. Jim didn't just give us software credits, he offered advice, introduced us to influencers, industry insiders, and sales veterans who he promptly converted to believers themselves. The army of people at Microsoft who help us every day with everything from technology to marketing advice are here because Jim recruited them," says Mitchell. "No one knows health care better than Microsoft and we are proud to announce initial positive results from our collaboration with the company." ORHub is a cloud-based software platform focused on delivering value-based medicine in surgical care. The company enables all parties involved in surgical care to work together to organize, deliver, measure and reimburse in a single uniform process. This allows for significant decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions that result from siloed processes in software and poor handoffs from one part of the care process to another. The need for ORHub is clear. Health care comprises more than 17% of US GDP at over $3 trillion dollars per year. With costs rising every year due to an aging population and more expensive treatments, providers are under severe pressure to become more efficient and reduce costs from payers who are aggressively reducing reimbursements and finally moving away from fee-for-service and toward performance-based reimbursement. ORHub enables providers to thrive in this new environment by addressing the single largest segment of health care, which is surgical care. ORHub replaces numerous legacy systems with a 360 degree system that is focused on tracking cost from diagnosis to discharge centered on treating a patient for a specific condition. ORHub has offices at Phoenix, Arizona; Newport Beach, California; and Bellevue, Washington. This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the Company believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurances that its expectations will be attained. Such statements are inherently uncertain, and actual results and activities may differ materially from those estimated or projected. Certain factors that can affect the Company's ability to achieve its anticipated results include, among others, uncertainties inherent in the development of a new software product business.


PubMed | Hospital Regional, Servicio de Nefrologia and Hospital Torrecardenas
Type: Journal Article | Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia | Year: 2016

Renal failure is one of the main causes of death in patients with Fabry disease (FD). Due to the low prevalence of FD, delayed diagnosis and misdiagnosis, often the correct diagnosis is made when organ damage is already present. Early recognition of the disease would allow the prevention of severe complications and the premature death of patients with FD.We present here the PrEFiNE project, which includes a wide spectrum of activities with the aim of improve knowledge and diagnosis of FD. The project is sponsored by Shire Iberia (http://shireiberica.com/)From January 2016 to the end of 2017 several activities will be carried out, starting with a survey to evaluate current FD knowledge among nephrologists; in addition some studies to assess prevalence of this disease will be performed. One study will include patients receiving dialysis, another study will cover kidney transplant patients, and a pilot study in chronic kidney disease in stage 3-5 predialysis. Also planned is a pharmacoeconomic study to focus on burden of FD. At the same time medical education activities will be conducted both on line and on site. Plan for dissemination will include medical publications and diffusion to media. PrEFiNE Project will finish with the publication of a compilation book on FD in Nephrology including all planned activities and proposing recommendations based on results and detected unmet needs. PrEfiNE Plan will be coordinated by severa scientific committees, one at national level and 10 other regionals comittees, tha will be responsible to ensure the maximum scientific quality of proposed activities. An advisory board will supervise the project.PrEfiNE project will evaluate an action plan focused on improving FD knowledge to make necessary recommendations for an early recognition of the disease. In addition will generate a plan to improve previously undetected needs.


Halsey E.S.,Us Naval Medical Research Unit No 6 | Siles C.,Us Naval Medical Research Unit No 6 | Guevara C.,Us Naval Medical Research Unit No 6 | Vilcarromero S.,Us Naval Medical Research Unit No 6 | And 4 more authors.
Emerging Infectious Diseases | Year: 2013

During 2010-2013, we recruited 16 persons with confirmed Mayaro virus infection in the Peruvian Amazon to prospectively follow clinical symptoms and serologic response over a 12-month period. Mayaro virus infection caused long-term arthralgia in more than half, similar to reports of other arthritogenic alphaviruses.


News Article | March 2, 2017
Site: www.accesswire.com

Effort Poised to Result in Major Reductions in Surgical Costs and Improved Outcomes NEWPORT BEACH, CA / ACCESSWIRE / March 2, 2017 / ORHub, Inc. (OTC PINK: ORHB), a cloud-based health care software-as-a-service (SaaS) company focused on decreasing costs and increasing outcomes in surgical care, announces a new solution built on Microsoft Azure that's focused on the single biggest cost center for healthcare - surgery. Many hospitals and vendors today are struggling with rising costs, decreasing margins, and uneven quality, despite the hard work of well-intentioned, well-trained professionals. Without understanding the true costs of care for patient conditions, much less how costs are related to outcomes, health care organizations are flying blind in deciding how to improve efficiency and increase quality. Legacy delivery approaches, payment structures, and software which have largely remained unchanged for decades, have reinforced the problem and produced a system with erratic quality and unsustainable costs. ORHub has solved this problem by creating a value-based solution that tracks the cost of treating a condition from diagnosis to discharge, and then tracking outcomes that resulted from that treatment. ORHub's platform enables all parties involved in surgical care to organize, deliver, measure, and reimburse in a streamlined process. This allows for significant decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions that result from siloed processes in software and poor handoffs from one part of the care process to another. Installations of ORHub's solution are in full production usage daily at two major southern California hospitals, both of which are members of the nation's second largest non-profit hospital system. Hospital Regional President and CEO, Richard Afable, stated that ORHub was "one of those innovative new systems that can, and will, provide for us the kind of information, the kind of data that we need in order to take better care of patients and to do it more effectively and more efficiently." "We've had an extraordinarily productive year working with Microsoft," says Wesley Mitchell, Chief Technology Officer of ORHub. "We went from concept to production in less than a year in Institutional Medicine. We couldn't have done that without the knowledge and expertise of our friends at Microsoft. They cleared the way for us in terms of technology and regulatory safety by building platforms like Microsoft Azure which enables HIPAA compliance so that we could focus on what's most important to us: delivering value to our customers." ORHub worked with Microsoft for Startups on a variety of technical engagements that helped create the digital platform's initial architecture. The design of the solution is based on the recognition that today's siloed health care software is fundamentally incompatible with a value-based approach, which emphasizes that organizations wanting to practice value-based health care need software built from the ground-up with that goal in mind. "ORHub's solution on Microsoft Azure has the potential to have a big impact on one of the costliest areas of healthcare - surgery - bringing efficiencies to its customers and savings to patients," said Jim Brisimitzis, General Manager, Microsoft for Startups at Microsoft Corp. "Azure's global scale, security and compliance portfolio make it the ideal cloud platform for health organizations and the partners that serve them." During early product development, the Microsoft for Startups team also helped ORHub with customer introductions, which proved to be impactful for clearly understanding customer needs and helped the Company avoid potential pitfalls in structuring its technology and contracts. With a year of production in play, ORHub has received overwhelming interest in its platform, and is now in discussions with health care providers across the United States. Institutions that have adopted a value-based model have reaped savings of 20-40% on their overall cost of care. ORHub allows participating hospitals to avoid the long, drawn out consulting approach to adopting a value-based model by providing a comprehensive tool that is value-based by design. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities. ORHub recently launched its second major hospital customer, and plans to roll-out to 1,100 hospitals in the next 18 months. "Before we even wrote out our first architecture diagram, we were having coffee with Jim and planning out our strategy together. Jim didn't just give us software credits, he offered advice, introduced us to influencers, industry insiders, and sales veterans who he promptly converted to believers themselves. The army of people at Microsoft who help us every day with everything from technology to marketing advice are here because Jim recruited them," says Mitchell. "No one knows health care better than Microsoft and we are proud to announce initial positive results from our collaboration with the company." ORHub is a cloud-based software platform focused on delivering value-based medicine in surgical care. The company enables all parties involved in surgical care to work together to organize, deliver, measure and reimburse in a single uniform process. This allows for significant decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions that result from siloed processes in software and poor handoffs from one part of the care process to another. The need for ORHub is clear. Health care comprises more than 17% of US GDP at over $3 trillion dollars per year. With costs rising every year due to an aging population and more expensive treatments, providers are under severe pressure to become more efficient and reduce costs from payers who are aggressively reducing reimbursements and finally moving away from fee-for-service and toward performance-based reimbursement. ORHub enables providers to thrive in this new environment by addressing the single largest segment of health care, which is surgical care. ORHub replaces numerous legacy systems with a 360 degree system that is focused on tracking cost from diagnosis to discharge centered on treating a patient for a specific condition. ORHub has offices at Phoenix, Arizona; Newport Beach, California; and Bellevue, Washington. This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the Company believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurances that its expectations will be attained. Such statements are inherently uncertain, and actual results and activities may differ materially from those estimated or projected. Certain factors that can affect the Company's ability to achieve its anticipated results include, among others, uncertainties inherent in the development of a new software product business.


De Souza Neto E.P.,Groupement Hospitalier Est | De Souza Neto E.P.,Ecole Normale Superieure de Lyon | De Souza Neto E.P.,Hospital Regional | Grousson S.,Groupement Hospitalier Est | And 7 more authors.
British Journal of Anaesthesia | Year: 2011

Dynamic variables are accurate predictors of fluid responsiveness in adults undergoing mechanical ventilation. They can be determined using respiratory variation in aortic flow peak velocity (Vpeak), arterial pulse pressure [PP and pulse pressure variation (PPV)], or plethysmographic waveform amplitude [POP and pleth variability index (PVI)]. These indices have not been validated in children. We studied the ability of these variables to predict fluid responsiveness in mechanically ventilated children. Methods. All results are expressed as median [median absolute deviation (MAD)]. Thirty mechanically ventilated children were studied after undergoing general anaesthesia. Mechanical ventilation was maintained with a tidal volume of 10 ml kg -1 of body weight. PP, PPV, POP, PVI, Vpeak, and aortic velocitytime integral were recorded before and after volume expansion (VE). Patients were considered to be responders to VE when the aortic velocitytime integral increased more than 15 after VE. Results. VE induced significant changes in PP [13 (MAD 4) to 9 (5)], PPV [15 (5) to 9 (5)], POP [15 (10) to 10 (6)], PVI [13 (6) to 8 (5)], and Vpeak [16 (9) to 8 (3)] (P<0.05 for all). Differences in PP, POP, PPV, and PVI did not reach statistical significance. Only Vpeak was significantly different between responders (R) and non-responders (NR) to VE [22 (3) vs 7 (1), respectively; P<0.001]. The threshold Vpeak value of 10 allowed discrimination between R and NR. Conclusion. sIn this study, Vpeak was the most appropriate variable to predict fluid responsiveness. © The Author [2011].


PubMed | Autonomous University of Tamaulipas and Hospital Regional < >
Type: | Journal: Cirugia y cirujanos | Year: 2016

Splenic abscesses are rare entities; reports are commonly described in immunocompromised patients (72%) as: hematologic diseases, diabetes, endocarditis, acquired immunodeficiency syndrome, transplant patients and subjects who had abdominal trauma or splenic infarction. The main and most serious complication is the abscess rupture into the peritoneal cavity or adjacent organs (stomach or colon), which determines hemodynamic instability or septic state.Fifty-year-old man, who was admitted at Emergency Room due eight days progressive, oppressive, and current pain; intensity 4/10, irradiated at hemi-back, which was higher intensity during the standing and decreased at supine position. It was accompanied by nausea and vomiting in two occasions.Hemoglobin 15.1g/dl, hematocrit 45.2%, platelets 17610At presence of free air inside the abdominal cavity, is usually to think of a complicated diverticular disease, intestinal perforation or perforated peptic ulcer. The actual medical literature described very few cases of splenic abscess with pneumoperitoneum as cardinal manifestation. In our case, the splenic abscess was detected during exploratory laparotomy and only in retrospective the imaging studies were interpreted.


PubMed | University of Guanajuato, Hospital Regional and Autonomous University of Guadalajara
Type: Journal Article | Journal: Cirugia y cirujanos | Year: 2016

Evidence of the benefit on propioceptive neuromuscular facilitation for reducing falls in older people does not exist.The aim of this study is to evaluate the effects of propioceptive facilitation over falls and biomechanical variables, in comparison to standard treatment and control groups.Series cases comparative for the 24 participants were recruited and randomnly assigned to 3 groups. Group 1, propioceptive neuromuscular facilitation, group 2, standard treatment, and 3 control. Falls and biomechanic variables were measured before and after. Chi(2) was used for falls and multiple regression for biomechanical variables,Participants had similar falls in previous year. Women had higher falls in a relation 7:1 women-men. After intervention, there was no difference between 3 groups. A correlation exista between muscular strength and gait speed with one foot position time r(2) = 0.67, p = 0.02.Improving 1kilogram-force of muscular strength of pelvic limb and 0.1meter/second in gait speed, balance (unipodal position time) increases balance by 11.3%. After 3 months of intervention group 2 got 7.9kg-force and 0.26m/s of profit, while group 1 had 4.1kg-force and 0.15m/s and control group 2.4kg-force and 0.1m/s.


PubMed | Hospital Regional < >
Type: Journal Article | Journal: Cirugia y cirujanos | Year: 2016

The risk of post-operative pneumonia is a latent complication. A study was conducted to determine its risk factors in abdominal surgery.A cross-sectional study was performed that included analysing the variables of age and gender, chronic obstructive pulmonary disease and smoking, serum albumin, type of surgery and anaesthesia, emergency or elective surgery, incision site, duration of surgery, length of hospital stay, length of stay in the intensive care unit, and time on mechanical ventilation. The adjusted odds ratio for risk factors was obtained using multivariate logistic regression.The study included 91 (9.6%) patients with pneumonia and 851 (90.4%) without pneumonia. Age 60 years or over (OR=2.34), smoking (OR=9.48), chronic obstructive pulmonary disease (OR=3.52), emergency surgery (OR=2.48), general anaesthesia (OR=3.18), surgical time 120 minutes or over (OR=5.79), time in intensive care unit 7 days or over (OR=1.23), time on mechanical ventilation greater than or equal to 4 days (OR=5.93) and length of post-operative hospital stay of 15 days or over (OR=1.20), were observed as independent predictors for the development of postoperative pneumonia.Identifying risk factors for post-operative pneumonia may prevent their occurrence. The length in the intensive care unit of greater than or equal to 7 days (OR=1.23; 95% CI 1.07 - 1.42) and a length postoperative hospital stay of 15 days or more (OR=1.20; 95% CI 1.07 - 1.34) were the predictive factors most strongly associated with lung infection in this study.

Loading Hospital Regional collaborators
Loading Hospital Regional collaborators